Clinical and Molecular Evolution of an ALK -Driven Infant-Type Hemispheric Glioma Treated Sequentially With Second- and Third-Generation Anaplastic Lymphoma Kinase Inhibitors
JCO Precision Oncology · 2023-03 · (7)
DOI: 10.1200/po.22.00547 ↗Kurz gefasst
Fallbericht in der Zeitschrift JCO Precision Oncology, 2023-03. Verfasst von Nagore Gene-Olaciregui und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Oncology, Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu, Barcelona, Spain. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Glioma, Lung Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Molecular Oncology, Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu, Barcelona, Spain.
- Neuro Oncology Unit, Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu, Barcelona, Spain.
- Children & Young People's Unit, The Royal Marsden NHS Foundation Trust, London, United Kingdom.
- Laboratory of Developmental Tumor Biology, Institut de Recerca Sant Joan de Déu, Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu, Barcelona, Spain.
- Pediatric Solid Tumor Unit, Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu, Barcelona, Spain.
- Department of Pathology, Hospital Sant Joan de Déu, Barcelona, Spain.
ORCID-Profile: Marta Perez-Somarriba, Vicente Santa-María, Soledad Gómez-González, Carlota Rovira, Jordi Muchart, José Hinojosa, Andrés Morales La Madrid, Cinzia Lavarino
Zitieren
APA
Gene-Olaciregui, N., Perez-Somarriba, M., Santa-María, V., Cruz, O., Gómez-González, S., Castañeda, A., Suñol, M., Rovira, C., Muchart, J., Hinojosa, J., La Madrid, A. M., & Lavarino, C. (2023). Clinical and Molecular Evolution of an ALK -Driven Infant-Type Hemispheric Glioma Treated Sequentially With Second- and Third-Generation Anaplastic Lymphoma Kinase Inhibitors. JCO Precision Oncology. https://doi.org/10.1200/po.22.00547
Vancouver
Gene-Olaciregui N, Perez-Somarriba M, Santa-María V, Cruz O, Gómez-González S, Castañeda A, et al. Clinical and Molecular Evolution of an ALK -Driven Infant-Type Hemispheric Glioma Treated Sequentially With Second- and Third-Generation Anaplastic Lymphoma Kinase Inhibitors. JCO Precision Oncology. 2023. doi:10.1200/po.22.00547
BibTeX
@article{GeneOlaciregui2023,
author = {Gene-Olaciregui, Nagore and Perez-Somarriba, Marta and Santa-María, Vicente and Cruz, Ofelia and Gómez-González, Soledad and Castañeda, Alicia and Suñol, Mariona and Rovira, Carlota and Muchart, Jordi and Hinojosa, José and La Madrid, Andrés Morales and Lavarino, Cinzia},
title = {Clinical and Molecular Evolution of an ALK -Driven Infant-Type Hemispheric Glioma Treated Sequentially With Second- and Third-Generation Anaplastic Lymphoma Kinase Inhibitors},
journal = {JCO Precision Oncology},
year = {2023},
number = {7},
doi = {10.1200/po.22.00547}
}
EUVIMED